Intrexon reported $-17414000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -35997000 20.08M
Amgen AMGN:US $ 2500M 196M
Anika Therapeutics ANIK:US $ -3554000 5.35M
Arrowhead Research ARWR:US $ 41.55M 104.87M
AstraZeneca AZN:LN 2.88B 1.57B
Bluebird Bio BLUE:US $ -120346000 138.95M
Bristol Myers Squibb BMY:US $ 3188M 399M
Chemocentryx CCXI:US $ -38233000 1.82M
Gilead Sciences GILD:US $ 2897M 1957M
GlaxoSmithKline GSK:LN 2.42B 724M
Heron Therapeutics HRTX:US $ -62923000 9.39M
Immunogen IMGN:US $ -22852000 11.7M
Intrexon XON:US $ -17414000 3.07M
Karyopharm Therapeutics KPTI:US $ -34586000 81.55M
Ligand Pharmaceuticals LGND:US $ -9306000 22.04M
Macrogenics MGNX:US $ -66638000 8.4M
Mannkind MNKD:US $ -23239000 2.29M
Merk MRK:US $ 5059M 207M
Novartis NOVN:VX 3.15B 266M
Peregrine Pharmaceuticals PPHM:US $ 3.27M 884K
Rigel Pharmaceuticals RIGL:US $ -26261000 8.36M
Sangamo Biosciences SGMO:US $ -45261000 5.36M
Thermo Fisher Scientific TMO:US $ 2823M 128M
Veracyte VCYT:US $ -15248000 6.72M
Xencor XNCR:US $ 26.47M 65.19M
YTE INCY:US $ 127.66M 7.71M
Ziopharm Oncology ZIOP:US $ -9085000 1.23M